To validate whether GPR65 on TAMs indeed functions as the critical sensor for lactate signaling in the TME to drive tumor progression, we transfected TAMs with either shNC (negative control shRNA) or shGPR65 (GPR65-silencing shRNA). The gene discussed is GPR65; the disease is neoplasm.